Golden
Revance Therapeutics

Revance Therapeutics

A company that develops and commercializes products for the treatment of dermatological diseases

Revance Therapeutics is a publicly held biotechnology company based in Newark, California. It specializes in developing neuromodulators for the treatment of asthetic and therapeutic conditions. Revance uses a proprietary stabilizing excipient peptide technology to create differentiated therapies.

The company's lead product candidate, RT002 (DaxibotulinumtoxinA) for injection, is in clinical development for a broad range of aesthetic and therapeutic indications, including:

Glabellar Lines

The skin that sits between the eyebrows and above the nose. Face wrinkling is promoted by habitual facial expressions, aging, sun damage, smoking, poor hydration, and various other factors. Late stage clinical studies have produced positive results, with RT002 poised to progress to commercialization. Revance has also entered into an agreement with Fosun Pharmaceuticals for the exclusive rights to develop and commercialize RT002 in Mainland China, Hong Kong, and Macau.

Cervical Dystonia

An extremely painful, chronic neurological movement disorder where the neck and shoulder muscles contract involuntarily and contort, causing the head to twist or turn to the left, right, upwards, and/or downwards. RT002 has completed Phase 2 clinical trials for this condition.

A subacute, degenerative process that often results in debilitating pain located in the heel and bottom of the foot. RT002 is entering Phase 2 clinical trials for this condition.

Hyperhidrosis

A skin disorder characterized by abnormally increased sweating in excess of that required for thermoregulation. RT002 in the pre-clinical stage for this condition.

Timeline

People

Name
Role
Related Golden topics

Abhay Joshi

COO

Austen Dake

Employee

Azhar Ghani

Employee

C. Richard Garfield

Employee

Caryn McDowell

Senior VP, General Counsel & Corporate Secretary

Dan Browne

Co-Founder, President & CEO

Joseph Di Lembo

Employee

Justin Ford

VP, Human Resources and Head of People

Luciana Miranda

Employee

Mahady Sarwary

Employee

Maria Millan

Employee

Max Lavie

Investor

Phil Kennedy

Employee

Sam Manoucheri

Employee

Tobin Schilke

CFO

Further reading

Title
Author
Link
Type

Revance Therapeutics reaches licensing agreement with Fosun Pharmaceutical over botox formulation RT002

Sarah Toy

Web

Why this East Bay drug maker's stock price nearly doubled last year

Ron Leuty

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References